Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 68001-493

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 68001-493). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton 20ml (Spl Doxorubicin Carton 1)

Packaging label for Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) injectable liposomal formulation. Includes dosage instructions, storage conditions (2°C to 8°C), and manufacturer information (Sun Pharmaceutical Industries Ltd. for BluePoint Laboratories). Label emphasizes dilution prior to administration and intravenous infusion only. Contains barcodes and regulatory details.*

FDA Label Image

Carton 25ml (Spl Doxorubicin Carton 2)

Packaging label for Doxorubicin Hydrochloride Liposome Injection, 2 mg/mL (50 mg/25 mL) sterile injectable liposomal formulation. The label indicates it is for intravenous infusion only after dilution, is a cytotoxic agent, and must be diluted prior to administration. Manufactured by Sun Pharmaceutical Industries Ltd. for BluePoint Laboratories. Includes storage instructions to keep refrigerated at 2°C to 8°C and not to freeze.*

FDA Label Image

Spl-doxorubicin-figure (Spl Doxorubicin Figure)

An illustration diagram showing a cross-sectional representation of a pegylated liposome containing doxorubicin hydrochloride. The diagram labels the MPEG-DSPE coating, the aqueous core with entrapped doxorubicin HCl, and the liposomal bilayer surrounding the core.*

FDA Label Image

Spl-doxorubicin-figure1 (Spl Doxorubicin Figure1)

A Kaplan-Meier survival curve showing percent of subjects progression-free over time (months) comparing two groups: Doxorubicin + Bortezomib versus Bortezomib alone. The plot includes p-value, hazard ratio with 95% confidence interval, censored data points, and a table of the number of subjects at risk at specified time intervals.*

FDA Label Image

Label 10ml (Spl Doxorubicin Label 1)

Label for Doxorubicin Hydrochloride Liposome Injection, 20 mg/10 mL (2 mg/mL) injectable liposomal solution in a 10 mL single-dose vial. It is a cytotoxic agent requiring dilution. Manufactured by Sun Pharmaceutical Industries Ltd. for BluePoint Laboratories. Includes storage instructions, caution about dilution, and reference to prescribing information.*

FDA Label Image

Label (Spl Doxorubicin Label 2)

Label for Doxorubicin Hydrochloride Liposome Injection, 50 mg/25 mL (2 mg/mL) injectable liposomal formulation for intravenous use. The 25 mL single-dose vial is a cytotoxic agent and must be diluted before use. Manufactured by Sun Pharmaceutical Industries Ltd. for BluePoint Laboratories, with storage instructions at 2°C to 8°C and warnings not to freeze. The label includes dosing instructions and lot/expiry placeholders.*

FDA Label Image

Spl-doxorubicin-structure (Spl Doxorubicin Structure)

Chemical structure diagram of doxorubicin hydrochloride, showing the arrangement of rings, hydroxyl groups, carbonyl groups, and associated hydrochloride moiety.*

FDA Label Image

Spl-doxorubicin-structure1 (Spl Doxorubicin Structure1)

Chemical structure diagram of MPEG-DSPE, a component commonly used in liposomal formulations, showing its molecular arrangement with polyethylene glycol and phospholipid groups.*

FDA Label Image

Spl-doxorubicin-structure2 (Spl Doxorubicin Structure2)

Chemical structure diagram of HSPC (Hydrogenated Soy Phosphatidylcholine) showing atoms and bonds, including phosphate, choline, and fatty acid chains with notation indicating chain lengths of m and n as 14 or 16 carbons.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.